Prescription Monitoring Report, Early Refill, and the Duty to Resolve Red Flags
A patient presents at a Scottsdale pharmacy with a paper prescription for a 30-day supply of a Schedule IV benzodiazepine and a 30-day supply of a Schedule II stimulant, both written by the same prescriber on the same day. The state prescription monitoring program report shows the patient received a 30-day benzodiazepine supply 12 days ago from a different pharmacy and a stimulant supply 20 days ago from a third pharmacy. The patient says the earlier prescriptions were lost in a move and asks the pharmacist to fill both today. The pharmacist also notes the patient is 19 years old and the prescriber is a family practice physician.
1. Identify the red flags and explain what the pharmacist must do before dispensing.
Read the worked answer
The red flags are cumulative: two controlled substances from different schedules written on the same day; a monitoring report showing recent supplies of both drugs from two other pharmacies; a request to refill early because the earlier medication was lost; a young adult patient; and a prescriber in family practice rather than a specialist. Individually each may have an explanation; together they require the pharmacist to resolve the discrepancy before dispensing.
The pharmacist should not simply refuse and should not simply fill. The correct process is: review the monitoring report in full, including dates, quantities, and prescribers; contact the prescriber to confirm the current prescriptions and to discuss the earlier supplies; ask the patient for details about the loss and whether a police report was filed; and document each step. If the prescriber confirms the new prescriptions and the earlier supplies are explained, the pharmacist may exercise professional judgment to dispense, with counseling and a plan for follow-up. If the prescriber cannot be reached or the explanation does not hold, the pharmacist should decline to fill and document the reason.
The pharmacist's corresponding responsibility means the pharmacist shares accountability for ensuring the prescription has a legitimate medical purpose. Filling without inquiry because the prescriber signed it is not a defense.
2. The patient becomes upset and says the pharmacist is accusing them of drug seeking. How should the pharmacist respond, and what counseling should be provided if the prescriptions are ultimately filled?
Read the worked answer
The pharmacist should acknowledge the frustration without being defensive, explain that reviewing the monitoring report and contacting the prescriber is a routine step for controlled substances, and avoid language that implies accusation. A useful framing is that the pharmacist wants to make sure the patient does not end up with duplicate or conflicting supplies. The pharmacist should offer privacy for the conversation and give the patient a clear sense of how long the verification will take.
If the prescriptions are filled, counseling should cover: how to take each medication and whether they may be taken together; the risk of sedation and the danger of combining a benzodiazepine with alcohol or opioids; driving precautions; storage in a locked location; disposal of unused medication; and the importance of using one pharmacy so the record is complete. The pharmacist should also explain the early-refill policy and what to do if medication is lost again.
The pharmacist should document the counseling and the resolution of the red flags. If the pharmacist declines to fill, the patient should be told how to reach the prescriber and given a referral option, and the refusal and its basis should be documented factually.
3. What recordkeeping should the pharmacist complete regardless of the decision, and how does the monitoring program query fit into the pharmacy's obligations?
Read the worked answer
The pharmacist should document: the date and time of the monitoring program query and what it showed; the contact with the prescriber, including who was spoken to and what was confirmed; the patient's explanation of the earlier supplies; the decision reached and the reasoning; and any counseling given. If the pharmacist declines to fill, the record should state the specific unresolved discrepancy, not a general suspicion.
Querying the monitoring program is part of the pharmacist's duty of care for controlled substances, and the pharmacy should have a written policy on when queries are required - at minimum for new patients receiving controlled substances, for early refills, for overlapping prescriptions, and when red flags appear. The policy should specify who queries, how the result is retained, and how discrepancies are escalated.
The pharmacy should also review its pattern data: repeated early-refill requests from the same prescriber or patient population may warrant a conversation with the prescriber or a report to the board. Documenting individual decisions creates the record the pharmacy would need if its dispensing is later reviewed.